Publications by authors named "Iakunina I"

Aim: To evaluate metformin efficacy and safety in patients with gout and insulin resistance (IR).

Material And Methods: The trial included 26 patients with gout (criteria of the American collage of rheumatologists) and IR (index HOMA). The inclusion criteria were the following: absence of antigout therapy, normal hepatic and renal function, rejection of alcohol.

View Article and Find Full Text PDF

Aim: To determine clinical significance of laboratory markers of vascular endothelium activation in gout.

Material And Methods: A total of 16 males aged 31-68 years with gout entered the study. The diagnosis satisfied Vallas' criteria, duration of the disease varied from 1.

View Article and Find Full Text PDF

Aim: Comparison of a gout course in males and females.

Material And Methods: The trial enrolled 34 patients (17 females and 17 males). The patients were matched by age and the disease duration.

View Article and Find Full Text PDF

Patients with gout are at a high risk for drug-induced complications associated with the use of nonsteroidal anti-inflammatory drugs due to the baseline renal and hepatic abnormalities, metabolic disturbances, and concomitant diseases, such as arterial hypertension or type 2 diabetes mellitus. In this connection, it is expedient to use safer selective cycloxygenase-2 (COG-2) inhibitors. However, there are only single reports dealing with studies of the effectiveness and safety of selective COG-2 inhibitors in gout.

View Article and Find Full Text PDF

Aim: To examine gastric biopsies with polarization microscopy for detection of sodium monourate crystals (SMC).

Material And Methods: The trial included 20 patients with gout diagnosis (mean age 55.7 years, mean duration of the disease 12.

View Article and Find Full Text PDF

Aim: To evaluate the occurrence of immunoresistance (IR) syndrome in gout and its correlation with a gout course.

Material And Methods: Anthropometric parameters, blood lipid spectrum, levels of glucose, uric acid (UA), immunoreactive insulin, HOMA index were studied in 55 male patients with gout (mean age 50.1 +/- 7.

View Article and Find Full Text PDF

Aim: To evaluate efficacy and safety of nimesil, a selective inhibitor of cyclooxigenase-2, in gouty arthritis (GA).

Material And Methods: Nimesil was given to 20 male patients with GA (mean age 53.8 years, mean duration of the disease 8.

View Article and Find Full Text PDF